367 related articles for article (PubMed ID: 6801179)
21. Molecular analysis of the membrane attack mechanism of complement.
Kolb WP; Haxby JA; Arroyave CM; Müller-Eberhard HJ
J Exp Med; 1972 Mar; 135(3):549-66. PubMed ID: 5058233
[TBL] [Abstract][Full Text] [Related]
22. Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae.
Joiner KA; Warren KA; Brown EJ; Swanson J; Frank MM
J Immunol; 1983 Sep; 131(3):1443-51. PubMed ID: 6411816
[No Abstract] [Full Text] [Related]
23. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
Podack ER; Tschoop J; Müller-Eberhard HJ
J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
[TBL] [Abstract][Full Text] [Related]
24. C5b-7 and C5b-8 precursors of the membrane attack complex (C5b-9) are effective killers of E. coli J5 during serum incubation.
Bloch EF; Knight EM; Carmon T; McDonald-Pinkett S; Carter J; Boomer A; Ogunfusika M; Petersen M; Famakin B; Aniagolu J; Walker J; Gant R; Walters CS; Gaither TA
Immunol Invest; 1997 Jun; 26(4):409-19. PubMed ID: 9246562
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a two-domain structure of the terminal membrane C5b-9 complex of human complement.
Bhakdi S; Tranum-Jensen J
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5872-6. PubMed ID: 293689
[TBL] [Abstract][Full Text] [Related]
26. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
27. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
[TBL] [Abstract][Full Text] [Related]
28. Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium.
Guc D; Gulati P; Lemercier C; Lappin D; Birnie GD; Whaley K
Rheumatol Int; 1993; 13(4):139-46. PubMed ID: 8310205
[TBL] [Abstract][Full Text] [Related]
29. Transmembrane channel-formation by five complement proteins.
Müller-Eberhard HJ
Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
[TBL] [Abstract][Full Text] [Related]
30. Formation of transmural complement pores in serum-sensitive Escherichia coli.
Bhakdi S; Kuller G; Muhly M; Fromm S; Seibert G; Parrisius J
Infect Immun; 1987 Jan; 55(1):206-10. PubMed ID: 3539803
[TBL] [Abstract][Full Text] [Related]
31. On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.
Hammer CH; Nicholson A; Mayer MM
Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5076-80. PubMed ID: 1061092
[TBL] [Abstract][Full Text] [Related]
32. [Complement activation and biological activities].
Inoue K
Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
[No Abstract] [Full Text] [Related]
33. Bacterial killing by complement requires direct anchoring of membrane attack complex precursor C5b-7.
Doorduijn DJ; Bardoel BW; Heesterbeek DAC; Ruyken M; Benn G; Parsons ES; Hoogenboom BW; Rooijakkers SHM
PLoS Pathog; 2020 Jun; 16(6):e1008606. PubMed ID: 32569291
[TBL] [Abstract][Full Text] [Related]
34. Transmembrane channel formation by complement: functional analysis of the number of C5b6, C7, C8, and C9 molecules required for a single channel.
Ramm LE; Whitlow MB; Mayer MM
Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4751-5. PubMed ID: 6289316
[TBL] [Abstract][Full Text] [Related]
35. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
Fearon DT; Austen KF; Ruddy S
Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
[No Abstract] [Full Text] [Related]
36. Human platelet-initiated formation and uptake of the C5-9 complex of human complement.
Zimmerman TS; Kolb WP
J Clin Invest; 1976 Jan; 57(1):203-11. PubMed ID: 812888
[TBL] [Abstract][Full Text] [Related]
37. Domain structure, functional activity, and polymerization of trout complement protein C9.
Tomlinson S; Stanley KK; Esser AF
Dev Comp Immunol; 1993; 17(1):67-76. PubMed ID: 8449252
[TBL] [Abstract][Full Text] [Related]
38. C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.
Kitamura H; Matsumoto M; Nagaki K
Immunology; 1984 Nov; 53(3):575-82. PubMed ID: 6237987
[TBL] [Abstract][Full Text] [Related]
39. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
Tesh VL; Duncan RL; Morrison DC
J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
[TBL] [Abstract][Full Text] [Related]
40. Complement attack of altered outer membrane areas synthesized after inhibition of the 3-deoxy-D-manno-octulosonate pathway leads to cell death.
Goldman RC; Miller MF
J Immunol; 1989 Jan; 142(1):185-94. PubMed ID: 2535855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]